Diagnosis and Management of Chronic Kidney Disease- Mineral Bone Disease in Children

키워드

참고문헌 (31)

1. Andrassy KM, "Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'", Kidney Int, 84, pp.622~623 (2013)
2. Hogg RJ, "National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification", Pediatrics, 111(6 Pt 1), pp.1416~1421 (2003)
3. Hanudel MR, "Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder", Curr Osteoporos Rep, 15, pp.198~206 (2017)
4. Wesseling K, "Chronic kidney disease mineral and bone disorder in children", Pediatr Nephrol, 23, pp.195~207 (2008)
5. Isakova T, "Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease", Kidney Int, 79, pp.1370~1378 (2011)
6. Saito H, "Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo", J Biol Chem, 280, pp.2543~2549 (2005)
7. Portale AA, "Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency", J Clin Invest, 73, pp.1580~1589 (1984)
8. Naveh-Many T, "The Pas de Trois of Vitamin D, FGF23, and PTH", J Am Soc Nephrol, 28, pp.393~395 (2017)
9. Goodman WG, "Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis", N Engl J Med, 342, pp.1478~1483 (2000)
10. "Kidney Disease: Improving Global Outcomes CKDMBDUWG. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)", Kidney Int Suppl(2011), 7, pp.1~59 (2017)
11. Ziolkowska H, "Bone biopsy results and serum bone turnover parameters in uremic children", Acta Paediatr, 89, pp.666~671 (2000)
12. Haffner D, "Treatment of hyperphosphatemia : the dangers of aiming for normal PTH levels", Pediatr Nephrol, 35, pp.485~491 (2020)
13. Warady BA, "A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis", Pediatr Nephrol, 34, pp.475~486 (2019)
14. Haffner D, "Extrarenal effects of FGF23", Pediatr Nephrol, 32, pp.753~765 (2017)
15. Bacchetta J, "Treatment of hyperphosphatemia : the dangers of high PTH levels", Pediatr Nephrol, 35, pp.493~500 (2020)
16. McAlister L, "The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce", Pediatr Nephrol, 35, pp.501~518 (2020)
17. Fathallah-Shaykh S, "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease", Pediatr Nephrol, 33, pp.325~333 (2018)
18. Shroff R, "Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism : a randomized trial", Clin J Am Soc Nephrol, 7, pp.216~223 (2012)
19. Group KW, "KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary", Am J Kidney Dis, 53(3 Suppl 2), pp.S11~104 (2009)
20. Andreoli SP, "Calcium carbonate is an effective phosphorus binder in children with chronic renal failure", Am J Kidney Dis, 9, pp.206~210 (1987)
21. Mahdavi H, "Sevelamer hydrochloride : an effective phosphate binder in dialyzed children", Pediatr Nephrol, 18, pp.1260~1264 (2003)
22. Habbous S, "The efficacy and safety of sevelamer and lanthanum versus calciumcontaining and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease : a systematic review and meta-analysis", Nephrol Dial Transplant, 32, pp.111~125 (2017)
23. Sekercioglu N, "Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease : A Systematic Review and Network Meta-Analysis", PLoS One, 11, pp.e0156891~ (2016)
24. Floege J, "A phase III study of the efficacy and safety of a novel ironbased phosphate binder in dialysis patients", Kidney Int, 86, pp.638~647 (2014)
25. Hanudel MR, "Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients", Pediatr Nephrol, 33, pp.2137~2142 (2018)
26. Andreoli SP, "Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis", N Engl J Med, 310, pp.1079~1084 (1984)
27. Portale AA, "Disordered FGF23 and mineral metabolism in children with CKD", Clin J Am Soc Nephrol, 9, pp.344~353 (2014)
28. Shroff R, "Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis", Nephrol Dial Transplant, 32, pp.1098~1113 (2017)
29. Shroff R, "Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis", Nephrol Dial Transplant, 32, pp.1114~1127 (2017)
30. Investigators ET, "Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis", N Engl J Med, 367, pp.2482~2494 (2012)
31. Joseph C, "Cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients below age 5 years", Clin Nephrol, 92, pp.279~286 (2019)

관련 논문AI추천